Free Newsletter
Opportunity knocks for software makers


OK, software makers, you're up.
Drug developers need capacity-planning solutions--really good ones that account for resource costs (see related story). And they have to be up to the challenges of increasingly complex clinical trial protocols, including those for adaptive trials, and accurate enough to show cost savings.
Yes, you've provided clinical capacity-planning features within trial management solutions. But now it's time to step it up a notch, says Kenneth Kaitin of the Tufts Center for the Study of Drug Development.
The need is now for capacity-planning solutions based on an accurate understanding of resource costs. Here's your chance to shine.
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: